BLI Banque de Luxembourg Investments Sells 4,900 Shares of Agilent Technologies, Inc. $A

BLI Banque de Luxembourg Investments cut its holdings in Agilent Technologies, Inc. (NYSE:A) by 77.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,399 shares of the medical research company’s stock after selling 4,900 shares during the period. BLI Banque de Luxembourg Investments’ holdings in Agilent Technologies were worth $193,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Everett Harris & Co. CA bought a new position in Agilent Technologies during the fourth quarter valued at $207,000. Fox Run Management L.L.C. grew its holdings in Agilent Technologies by 210.1% during the fourth quarter. Fox Run Management L.L.C. now owns 14,781 shares of the medical research company’s stock valued at $2,011,000 after purchasing an additional 10,015 shares during the period. Cantillon Capital Management LLC grew its holdings in Agilent Technologies by 0.8% during the fourth quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock valued at $423,945,000 after purchasing an additional 23,493 shares during the period. LPL Financial LLC grew its holdings in Agilent Technologies by 21.9% during the fourth quarter. LPL Financial LLC now owns 150,503 shares of the medical research company’s stock valued at $20,479,000 after purchasing an additional 27,010 shares during the period. Finally, Erste Asset Management GmbH grew its holdings in Agilent Technologies by 22.8% during the fourth quarter. Erste Asset Management GmbH now owns 146,509 shares of the medical research company’s stock valued at $19,986,000 after purchasing an additional 27,237 shares during the period.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Morgan Stanley reduced their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. UBS Group reduced their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Barclays increased their price objective on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Finally, Wells Fargo & Company reduced their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $161.71.

Agilent Technologies Trading Up 2.0%

NYSE:A opened at $135.39 on Wednesday. The company has a market cap of $38.24 billion, a P/E ratio of 27.19, a P/E/G ratio of 2.36 and a beta of 1.26. The stock’s fifty day moving average price is $119.23 and its two-hundred day moving average price is $128.09. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 5.99 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.